Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort

被引：0

作者：

Wu, L. ^{[1
]}

Zhu, J. ^{[2
]}

Yin, R. ^{[3
,4
]}

Wu, X. ^{[5
]}

Lou, G. ^{[6
]}

Wang, J. ^{[7
]}

Gao, Y. ^{[8
]}

Kong, B. ^{[9
]}

Lu, X. ^{[10
]}

Zhou, Q. ^{[11
]}

Wang, Y. ^{[12
]}

Chen, Y. ^{[13
]}

Lu, W. ^{[14
]}

Li, W. ^{[15
]}

Cheng, Y. ^{[16
]}

Liu, J. ^{[17
,18
]}

Ma, X. ^{[19
]}

Zhang, J. ^{[19
]}

机构：

[1] Chinese Acad Med Sci, Canc Hosp, Gynecol Oncol, Beijing, Peoples R China

[2] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China

[3] Sichuan Univ, Dept Gynecol & Obstet, Chengdu, Sichuan, Peoples R China

[4] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu, Sichuan, Peoples R China

[5] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol Oncol, Shanghai, Peoples R China

[6] Harbin Med Univ, Canc Hosp, Dept Gynecol & Oncol, Harbin, Heilongjiang, Peoples R China

[7] Hunan Canc Hosp, Dept Gynecol Oncol, Changsha, Hunan, Peoples R China

[8] Beijing Canc Hosp, Dept Gynecol Oncol, Beijing, Peoples R China

[9] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China

[10] Fudan Univ, Dept Gynecol Oncol, Obstet & Gynecol Hosp, Shanghai, Peoples R China

[11] Chongqing Canc Hosp, Chongqing Off Canc Control & Res, Chongqing, Peoples R China

[12] Xian Jiatong Univ, Sch Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China

[13] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Peoples R China

[14] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China

[15] First Hosp Jilin Univ, Ctr Oncol, Changchun, Jilin, Peoples R China

[16] Jilin Canc Hosp, Div Thorac Oncol, Changchun, Jilin, Peoples R China

[17] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[18] Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[19] AstraZeneca, Clin Dev, Shanghai, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

230P

引用

页数：1

共 50 条

[41] Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Xia, Yue Yin
Lubinski, Jan
Rosen, Barry
Moller, Pal
Eisen, Andrea
Ainsworth, Peter
Senter, Leigha
Neuhausen, Susan
Singer, Christian
Brooks, Jennifer
Sun, Ping
Narod, Steven
Kotsopoulos, Joanne
MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S50 - S51
[42] BRCA1 and BRCA2 Mutations in Ovarian Cancer Reply
Zhang, Wei
Yang, Da
Sood, Anil K.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 360 - 361
[43] Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
Kim, Shana J.
Lubinski, Jan
Huzarski, Tomasz
Moller, Pal
Armel, Susan
Karlan, Beth Y.
Senter, Leigha
Eisen, Andrea
Foulkes, William D.
Singer, Christian F.
Tung, Nadine
Bordeleau, Louise
Neuhausen, Susan L.
Olopade, Olufunmilayo, I
Eng, Charis
Weitzel, Jeffrey N.
Fruscio, Robert
Narod, Steven A.
Kotsopoulos, Joanne
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2038 - 2043
[44] Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation
Synowiec, Agnieszka
Wcislo, Gabriel
Bodnar, Lubomir
Szczylik, Cezary
GINEKOLOGIA POLSKA, 2012, 83 (01) : 51 - 56
[45] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Milne, Roger L.
Osorio, Ana
Ramon y Cajal, Teresa
Baiget, Montserrat
Lasa, Adriana
Diaz-Rubio, Eduardo
de la Hoya, Miguel
Caldes, Trinidad
Teule, Alex
Lazaro, Conxi
Blanco, Ignacio
Balmana, Judith
Sanchez-Olle, Gessami
Vega, Ana
Blanco, Ana
Chirivella, Isabel
Esteban Cardenosa, Eva
Duran, Mercedes
Velasco, Eladio
Martinez de Duenas, Eduardo
Tejada, Maria-Isabel
Miramar, Maria-Dolores
Calvo, Maria-Teresa
Guillen-Ponce, Carmen
Salazar, Raquel
San Roman, Carlos
Urioste, Miguel
Benitez, Javier
BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
[46] BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, PL
King, MC
HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 705 - 713
[47] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Roger L. Milne
Ana Osorio
Teresa Ramón y Cajal
Montserrat Baiget
Adriana Lasa
Eduardo Diaz-Rubio
Miguel de la Hoya
Trinidad Caldés
Alex Teulé
Conxi Lázaro
Ignacio Blanco
Judith Balmaña
Gessamí Sánchez-Ollé
Ana Vega
Ana Blanco
Isabel Chirivella
Eva Esteban Cardeñosa
Mercedes Durán
Eladio Velasco
Eduardo Martínez de Dueñas
María-Isabel Tejada
María-Dolores Miramar
María-Teresa Calvo
Carmen Guillén-Ponce
Raquel Salazar
Carlos San Román
Miguel Urioste
Javier Benítez
Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
[48] BRCA1 and BRCA2 as ovarian cancer susceptibility genes
Sowter, HM
Ashworth, A
CARCINOGENESIS, 2005, 26 (10) : 1651 - 1656
[49] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Leendert H Zaaijer
Helena C van Doorn
Marian J E Mourits
Marc van Beurden
Joanne A de Hullu
Muriel A Adank
Luc R C W van Lonkhuijzen
Hans F A Vasen
Brigitte F M Slangen
Katja N Gaarenstroom
Ronald P Zweemer
Peggy M L H Vencken
Caroline Seynaeve
Mieke Kriege
British Journal of Cancer, 2016, 115 : 1174 - 1178
[50] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Zaaijer, Leendert H.
van Doorn, Helena C.
Mourits, Marian J. E.
van Beurden, Marc
de Hullu, Joanne A.
Adank, Muriel A.
van Lonkhuijzen, Luc R. C. W.
Vasen, Hans F. A.
Slangen, Brigitte F. M.
Gaarenstroom, Katja N.
Zweemer, Ronald P.
Vencken, Peggy M. L. H.
Seynaeve, Caroline
Kriege, Mieke
BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178

← 1 2 3 4 5 →